Turning Point Brands/$TPB
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Turning Point Brands
Turning Point Brands Inc operates as a manufacturer, marketer, and provider of consumer products that include Other Tobacco Products (OTP) in the U.S. The company offers a wide variety across the OTP spectrum, including moist snuff tobacco (MST), loose-leaf chewing tobacco, premium cigarette papers, make- your-own (MYO) cigar wraps, cigars, liquid vapor products, and tobacco vaporizer products. It operates in two segments, namely Zig-Zag products and Stoker's products segment. The company generates maximum revenue from the Zig-Zag products segment.
- Ticker
- $TPB
- Sector
- Consumer Essentials
- Primary listing
- NYSE
- Employees
- 484
- Headquarters
- Louisville, United States
- Website
- www.turningpointbrands.com
TPB Metrics
BasicAdvanced
$1.3B
28.82
$2.29
0.94
$0.32
0.49%
Price and volume
Market cap
$1.3B
Beta
0.94
52-week high
$146.90
52-week low
$54.17
Average daily volume
415K
Dividend rate
$0.32
Financial strength
Current ratio
5.669
Quick ratio
3.471
Long term debt to equity
0.672
Total debt to equity
0.684
Dividend payout ratio (TTM)
13.60%
Interest coverage (TTM)
2.26%
Profitability
EBITDA (TTM)
75.163
Gross margin (TTM)
56.74%
Net profit margin (TTM)
8.78%
Operating margin (TTM)
13.17%
Effective tax rate (TTM)
13.84%
Revenue per employee (TTM)
$1,050,000
Management effectiveness
Return on assets (TTM)
5.76%
Return on equity (TTM)
17.57%
Valuation
Price to earnings (TTM)
28.822
Price to revenue (TTM)
2.489
Price to book
3.07
Price to tangible book (TTM)
5.72
Price to free cash flow (TTM)
64.309
Free cash flow yield (TTM)
1.55%
Free cash flow per share (TTM)
1.024
Dividend yield (TTM)
0.48%
Forward dividend yield
0.49%
Growth
Revenue change (TTM)
24.49%
Earnings per share change (TTM)
-4.02%
3-year revenue growth (CAGR)
6.89%
10-year revenue growth (CAGR)
9.77%
3-year earnings per share growth (CAGR)
48.30%
10-year earnings per share growth (CAGR)
9.53%
3-year dividend per share growth (CAGR)
7.43%
What the Analysts think about TPB
Analyst ratings (Buy, Hold, Sell) for Turning Point Brands stock.
Analyst projections of the future price of Turning Point Brands stock.
Bulls say / Bears say
Modern Oral is scaling rapidly: Q2 net sales rose 128% year on year to $68.4 million and reached 48% of company sales. TPB raised its 2026 Modern Oral sales guidance in August and reaffirmed it in September. (Turning Point Brands, Turning Point Brands)
More retail access could extend growth: management expects chain-store count to rise 70% year on year by the end of 2026, with new shelf placements rolling out over several quarters. It is also expanding its sales force to support FRE and ALP distribution. (Exa)
Planned US nicotine-pouch manufacturing could improve unit economics over time. Management says it expects lower costs once production is scaled, with gross margins potentially reaching about 70%, although regulatory approval is still required. (Exa)
Profitability is weakening as TPB funds growth: Q2 adjusted EBITDA fell 50% and net income fell 75% year on year, while SG&A more than doubled. In September, the company narrowed its 2026 EBITDA outlook to $70–80 million and said it assumes no manufacturing margin benefit until 2027 and prolonged higher freight costs. (Turning Point Brands, Turning Point Brands)
The established businesses are under pressure: Zig-Zag sales fell 24.8% year on year in Q2, while heritage Stoker’s sales slipped 1% as loose-leaf declines offset moist-snuff share gains. Continued weakness would leave more of the growth burden on the newer pouch business. (Turning Point Brands)
FDA approval remains a material uncertainty for the pouch opportunity. TPB said its PMTA application was still pending, and FDA rules require premarket authorisation to market new tobacco products; its enforcement guidance is conditional rather than an authorisation. (Turning Point Brands, FDA)
Data summarised monthly by Lightyear AI. Last updated on 18 Oct 2026.
TPB Financial Performance
Revenues and expenses
TPB Earnings Performance
Company profitability
Upcoming events
TPB News
AllArticlesVideos
Funds containing TPB
Fund name | Fund size | $TPB weighting |
|---|---|---|
SPDR Russell 2000 US Small Cap€R2US | $5.3B | 0.05% |
SPDR Russell 2000 US Small Cap£R2SC | $5.3B | 0.05% |
Xtrackers MSCI World Small Cap$XSWC | $183M | 0.01% |
iShares MSCI World Small Cap€IUSN | $9B | 0.01% |
iShares MSCI World Small Cap$WSML | $9B | 0.01% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.


